Modern opportunities of interferons in treatment of children with COVID-19

Modern opportunities of interferons in treatment of children with COVID-19

Introduction. In 2020, most doctors were at the frontlines in the fight against the novel coronavirus infection (COVID-19). In the process of searching for effective etiotropic drugs, news came in that type I interferons had been successfully used for the treatment of COVID-19. Choosing the optimal...

Full description

Bibliographic Details
Main Authors:	Asiya I. Safina, Olga V. Sharipova, Ildus Ya. Lutfullin, Olga S. Naumova, Maria A. Daminova
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2021-03-01
Series:	Медицинский совет
Subjects:	interferons children new coronavirus infection covid-19 sars-cov-2
Online Access:	https://www.med-sovet.pro/jour/article/view/6028

Similar Items

COVID-19 in children: the accumulated experience?
by: A. I. Safina, et al.
Published: (2020-11-01)

Interferon-β: treatment option against COVID-19
by: Faiz Ul haq, et al.
Published: (2020-07-01)

Dysregulated Interferon Response Underlying Severe COVID-19
by: LeAnn Lopez, et al.
Published: (2020-12-01)

The value of interferon therapy for COVID-19 in children
by: L. N. Mazankova, et al.
Published: (2021-04-01)

A Role of Variance in Interferon Genes to Disease Severity in COVID-19 Patients
by: Leonid Gozman, et al.
Published: (2021-09-01)

Efficacy of Interferon Gamma in the Prevention of SARS-CoV-2 Infection (COVID-19): Results of a Prospective Controlled Trial
by: Alexander L. Myasnikov, et al.
Published: (2020-09-01)

Chilblains and COVID-19 - An Update on the Complexities of Interpreting Antibody Test Results, the Role of Interferon α, and COVID-19 Vaccines
by: Freeman, E.E, et al.
Published: (2022)

COVID-19: Knowns, Unknowns, and Questions
by: Stuart Weston, et al.
Published: (2020-03-01)

Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients
by: Marco Contoli, et al.
Published: (2021-03-01)

Immune evasion of SARS-CoV-2 from interferon antiviral system
by: Yuan-Qin Min, et al.
Published: (2021-01-01)

Experience of the use of hydroxychloroquine on patients with COVID-19: A perspective on viral load and cytokine kinetics
by: Wang-Da Liu, et al.
Published: (2021-05-01)

COVID-19 and Sarcoidosis, Readiness for Vaccination: Challenges and Opportunities
by: Michael Manansala, et al.
Published: (2021-04-01)

COVID-19 Presenting with Seizures
by: Sandeep Sohal, MD, et al.
Published: (2020-01-01)

COVID-19: A Devastating Pandemic
by: Punet Kumar, et al.
Published: (2020-11-01)

Features of tuberculosis diagnosis in the COVID-19
by: O. L. Ekaterincheva, et al.
Published: (2021-03-01)

COVID-19 and Indonesia
by: Siti Setiati, et al.
Published: (2020-04-01)

Primary Observational Results on Children Who Have Been Exposed to COVID-19 in Moscow
by: Dina S. Rusinova, et al.
Published: (2020-06-01)

The COVID-19 pandemic: a systematic review of the current evidence
by: R. Ghomi, et al.
Published: (2020-11-01)

Therapeutic Options for Coronavirus Disease 2019 (COVID-19) - Modulation of Type I Interferon Response as a Promising Strategy?
by: Aurélien Mary, et al.
Published: (2020-05-01)

Clinical-epidemiological characteristics of COVID-19
by: Manuel Ramon Perez Abereu, et al.
Published: (2020-04-01)

Novel Coronavirus Infection: COVID-19
by: Ergin ÇİFTÇİ, et al.
Published: (2020-03-01)

Treatment of severe pneumonia due to COVID-19 with peginterferon alfa 2a
by: Rania M. El-Lababidi, et al.
Published: (2020-01-01)

Malpractices environment due to lack of inputs during the COVID-19 pandemic in Latin America
by: Miguel Angel Montiel-Alfonso, et al.
Published: (2020-11-01)

Malpractices environment due to lack of inputs during the COVID-19 pandemic in Latin America
by: Miguel Angel Montiel-Alfonso, et al.
Published: (2020-11-01)

Epidemiologic profile of COVID-19 in Yateras, Guantanamo
by: Faustino Harriete-González, et al.
Published: (2021-03-01)

Type I Interferon Signature in Chilblain-Like Lesions Associated with the COVID-19 Pandemic
by: Roland Aschoff, et al.
Published: (2020-12-01)

Epidemiology of COVID-19
by: Sudipta Dhar Chowdhury, et al.
Published: (2020-03-01)

Rationale for COVID-19 Treatment by Nebulized Interferon-β-1b–Literature Review and Personal Preliminary Experience
by: Aurélien Mary, et al.
Published: (2020-11-01)

The Biometeorology of COVID-19: A Novel Therapeutic Strategy?
by: Elena Cantone, et al.
Published: (2020-01-01)

COVID-19: The first documented coronavirus pandemic in history
by: Yen-Chin Liu, et al.
Published: (2020-08-01)

Evasion of Type I Interferon by SARS-CoV-2
by: Hongjie Xia, et al.
Published: (2020-10-01)

Immune Status of COVID-19 Patients with Reference to SARS and MERS
by: Barani Karikalan, et al.
Published: (2020-05-01)

COVID-19: Current Developments and Further Opportunities in Drug Delivery and Therapeutics
by: Saman Zafar, et al.
Published: (2020-10-01)

A teenager with a severe form of COVID-19
by: L. N. Mazankova, et al.
Published: (2020-11-01)

“The Good, the Bad and the Ugly” in the First Year of COVID-19 Pandemic
by: Berkay Kapar, et al.
Published: (2021-03-01)

Interferon-β 1a and SARS Coronavirus Replication
by: Lisa E. Hensley, et al.
Published: (2004-02-01)

KG-COVID-19: A Framework to Produce Customized Knowledge Graphs for COVID-19 Response
by: Justin T. Reese, et al.
Published: (2021-01-01)

Urgent and emergent glaucoma care during the COVID-19 pandemic: An analysis at a tertiary care hospital in South India
by: Sharmila Rajendrababu, et al.
Published: (2021-01-01)

Visualizing an unseen enemy; mobilizing structural biology to counter COVID-19
by: Edward N. Baker
Published: (2020-05-01)

A Possible COVID-19 Reinfection Case in a Healthcare Professional
by: Erdinc Yavuz, et al.
Published: (2021-03-01)